Willard Police Chief Tom McClain has been in law enforcement for many decades, and has been the leader of Willard’s police force since 1993. He’s fought crime for years, ...
INGELHEIM, Germany and RIDGEFIELD, Conn., Dec. 22, 2025 Progressive pulmonary fibrosis (PPF) is a life-threatening, progressive lung condition, causing a ...
In 2025, respiratory news highlighted advances in lung imaging, expanded support for pulmonary rehabilitation and promising ...
The FDA has expanded the approval of Jascayd (nerandomilast), an oral phosphodiesterase 4 (PDE4) inhibitor, to include treatment of progressive pulmonary fibrosis in adults.
Police Chief Thomas McClain has worked in Willard for more than 30 years. Despite a serious health diagnosis, he is resolved ...
Following the recent approval of nerandomilast tablets for the treatment of idiopathic pulmonary fibrosis (IPF) in adults, the FDA has approved the medication for progressive pulmonary fibrosis as ...
On October 3, 2025, a multicenter team from Shenzhen University, Xiangya Hospital of Central South University, Zhujiang Hospital of Southern Medical University, Wuxi People's Hospital Affiliated to ...
A proof-of-concept trial shows novel sarcoidosis PET/CT tracer detects inflammatory activity, supporting further clinical ...
Repeated exposure to general anesthesia did not negatively affect neurobehavioral outcomes among children with cystic fibrosis, the randomized phase IV CF-GAIN trial showed. The mean composite score ...
DUBLIN, Jan. 7, 2026 /PRNewswire/ -- LUMA Vision Ltd., a leader in cardiac 4D navigation and imaging, today announced the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback